Literature DB >> 24492171

Thoracoscopic lobectomy as salvage surgery for local recurrence of non-small cell lung cancer after carbon ion radiotherapy in an initially operable patient.

Seiichiro Sugimoto1, Shinichi Toyooka, Ken Suzawa, Kouichi Ichimura, Osamu Fujii, Shinichiro Miyoshi.   

Abstract

Carbon ion radiotherapy (CIRT) for patients with early-stage non-small cell lung cancer (NSCLC) has recently provided favorable local control with very few toxic reactions. Because CIRT for NSCLC has been mostly performed for elderly or inoperable patients, salvage surgery for NSCLC after CIRT has rarely been reported. We describe a case of complete thoracoscopic right upper lobectomy with mediastinal lymphadenectomy performed as salvage surgery for local recurrence of stage IA NSCLC after CIRT in an initially operable patient who had refused surgery 27 months previously. Pleural adhesions caused by CIRT were localized to the pulmonary apex and the central pulmonary structures were intact at the time of the salvage surgery, which allowed us to successfully perform thoracoscopic lobectomy without any complications. Thus, salvage surgery for NSCLC after CIRT may be feasible in an initially operable patient, as CIRT appears to be unlikely to cause any difficulties in the salvage surgery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24492171     DOI: 10.5761/atcs.cr.13-00223

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  2 in total

Review 1.  Salvage surgery after high-dose radiotherapy.

Authors:  Annemie Van Breussegem; Jeroen M Hendriks; Patrick Lauwers; Paul E Van Schil
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

2.  Salvage surgery for local recurrence after carbon ion radiotherapy for lung cancer: A case report.

Authors:  Kantaro Hara; Nobuhiro Izumi; Takuma Tsukioka; Hiroaki Komatsu; Hidetoshi Inoue; Hikaru Miyamoto; Noritoshi Nishiyama
Journal:  Respir Med Case Rep       Date:  2020-05-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.